Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Eye injections aim to save sight in rare coats disease

NCT ID NCT03940690

First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 24 times

Summary

This study tested whether anti-VEGF injections into the eye can help treat Coats disease, a rare condition that causes abnormal blood vessels and fluid buildup in the retina, potentially leading to blindness. The trial included 18 people with early-stage Coats disease who had not received any prior eye treatment. Researchers compared the effects of these injections combined with standard laser therapy to see if they could improve the disease stage and reduce the need for repeated laser treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINAL TELANGIECTASIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU de Bordeaux

    Bourdeaux, 33076, France

  • CHU de Reims

    Reims, France, 51092, France

  • Centre hospitalier René Dubos (Pontoise)

    Cergy-Pontoise, France, 95303, France

  • Clinique Rive Gauche

    Toulouse, France, 31000, France

  • Fondation Ophtalmologique A. de Rothschild

    Paris, France, 75019, France

  • Hôpital Universitaire Necker Enfants Malades, APHP

    Paris, France, 75015, France

Conditions

Explore the condition pages connected to this study.